Updated COVID-19 shots lower hospitalization risk in immunocompromised people by a third
Receipt of an updated COVID-19 vaccine lowered the risk for hospitalization among immunocompromised people by around one-third, according to a study.
Receipt of an updated COVID-19 vaccine lowered the risk for hospitalization among immunocompromised people by around one-third, according to a study.
Sheeba K. Thomas The University of Texas MD Anderson Cancer Center, Houston, TX Sheeba K. Thomas, Jamie S George, Claudia M Morales de Partovi, Lei…
2233 S Martin Luther King Dr Chicago, IL 60616 Join Healio | HemOnc Today as we celebrate the risk-takers and groundbreakers at this prestigious awards…
Benjamin Avi Derman University of Chicago, Chicago, IL Benjamin Avi Derman, Jennifer H. Cooperrider, Tadeusz Kubicki, Ajay Major, Ken Jiang, Aubrianna Ramsland, Karson Buckley, Samrawit…
Lisa Freeman is tired of having to speak up when people refer to her as “a wheelchair” — the inanimate object she uses. She writes…
Discovery of higher GSDMB expression in children with a genetic defect linked to asthma explains why they commonly experience viral infections and face an elevated…
Nataliya Volodymyrivna Uboha University of Wisconsin Carbone Cancer Center, Madison, WI Nataliya Volodymyrivna Uboha, Yvonne M. Saenger, Olatunji B. Alese, Dae Won Kim, Lei Zheng,…
Standard treatment with neoadjuvant nivolumab plus chemotherapy significantly improves outcomes in patients with resectable non–small-cell lung cancer (NSCLC). Perioperative treatment (i.e., neoadj…
ASCO has issued new evidence-based updates to two living guidelines on the treatment of stage IV NSCLC with and without driver alterations.
Workload hidden in plain sight If you catch a train, there are hundreds of small processes that occur before you board the train to get…